Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 651.00 | 0.0031 | -0.9973 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 623.00 | 651.00 | 0.9570 | 0.9021 | |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 625.00 | 354.63 | 321.00 | 651.00 | 0.4931 | -0.1075 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 354.63 | 301.00 | 651.00 | 0.4624 | -0.1706 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 625.00 | 354.63 | 294.00 | 651.00 | 0.4516 | -0.1926 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 589.00 | 651.00 | 0.9048 | 0.7842 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 625.00 | 354.63 | 645.00 | 651.00 | 0.9908 | 0.9790 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 783.00 | 651.00 | 1.2028 | 1.4690 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 489.00 | 651.00 | 0.7512 | 0.4429 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 354.63 | 333.00 | 651.00 | 0.5115 | -0.0693 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 625.00 | 354.63 | 464.00 | 651.00 | 0.7128 | 0.3590 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 737.00 | 651.00 | 1.1321 | 1.3042 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 625.00 | 354.63 | 732.00 | 651.00 | 1.1244 | 1.2864 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 354.63 | 653.00 | 651.00 | 1.0031 | 1.0070 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 772.00 | 651.00 | 1.1859 | 1.4295 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 625.00 | 354.63 | 679.00 | 651.00 | 1.0430 | 1.0985 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 625.00 | 354.63 | 620.00 | 651.00 | 0.9524 | 0.8917 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 677.00 | 651.00 | 1.0399 | 1.0914 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 625.00 | 354.63 | 357.00 | 651.00 | 0.5484 | 0.0076 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 569.00 | 651.00 | 0.8740 | 0.7152 | |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 625.00 | 354.63 | 524.00 | 651.00 | 0.8049 | 0.5613 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 599.00 | 651.00 | 0.9201 | 0.8188 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 529.00 | 651.00 | 0.8126 | 0.5783 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 651.00 | 0.0031 | -0.9973 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 6.00 | 1644.00 | 0.0036 | -0.9951 |